Molecular Targets and Cancer Therapeutics

Document Sample
Molecular Targets and Cancer Therapeutics Powered By Docstoc
					AACR-NCI-EORTC International Conference
Molecular Targets and Cancer Therapeutics
Discovery, Biology, and Clinical Applications
                                                                            Table of Contents
                     Conference Committees..........................................................................................................................2
                     Conference Program and Schedule..........................................................................................................3
                     General Information ...............................................................................................................................6
                     Registration Form ...................................................................................................................................9
                     Hotel Information ................................................................................................................................10
                     Housing Information ............................................................................................................................11


    Organizing Committee                                         Janet E. Dancey, National Cancer Institute,                        David R. Parkinson, Amgen, Inc., Thousand
    AACR: Susan B. Horwitz, Albert Einstein                           Rockville, MD                                                       Oaks, CA
        College of Medicine, Bronx, NY                           Joseph P. Eder, Dana-Farber Cancer Institute,                      Yves G. Pommier, National Cancer Institute,
    NCI: Anna D. Barker, National Cancer Institute,                   Boston, MA                                                          Bethesda, MD
        Bethesda, MD                                             Alexander M. Marie Eggermont, University                           C. J. A. Punt, University Medical Center St.
    EORTC: Allan T. van Oosterom, University                          Hospital Rotterdam, Rotterdam, The                                  Radboud, Nijmegen, The Netherlands
        Hospital, Leuven, Belgium                                     Netherlands                                                   Eric Raymond, Institute Gustave-Roussy,
                                                                 Elizabeth A. Eisenhauer, Queen’s University,                             Villejuif, France
    Scientific Committee Chairpersons                                 Kingston, Ontario, Canada                                     Eddie Reed, West Virginia University,
    AACR: Charles L. Sawyers, University of                      Pierre Fumoleau, Centre René Gauducheau,                                 Morgantown, WV
        California, Los Angeles, CA                                   Nantes-St. Herblain, France                                   Patrick Schöffski, Hannover University Medical
    NCI: Edward A. Sausville, National Cancer                    Jackson B. Gibbs, Merck and Company, Inc.,                               School, Hannover, Germany
        Institute, Rockville, MD                                      West Point, PA                                                Judith S. Sebolt-Leopold, Pfizer Global Research
    EORTC: Jaap Verweij, Rotterdam Cancer                        Jennifer R. Grandis, University of Pittsburgh                            & Development, Ann Arbor, MI
        Institute, Rotterdam, The Netherlands                         School of Medicine, Pittsburgh, PA                            William R. Sellers, Dana-Farber Cancer
                                                                 Steven Grant, Medical College of Virginia,                               Institute, Boston, MA
    Scientific Committee                                              Richmond, VA                                                  Patricia S. Steeg, National Cancer Institute,
    Julian Adams, Millennium Pharmaceuticals, Inc.,              Louise B. Grochow, National Cancer Institute,                            Bethesda, MD
         Cambridge, MA                                                Rockville, MD                                                 Malcolm F. G. Stevens, University of
    Alex A. Adjei, Mayo Clinic, Rochester, MN                    Manuel Hidalgo, Johns Hopkins University                                 Nottingham, Nottingham, England
    Karen S. H. Antman, Columbia University, New                      School of Medicine, Baltimore, MD                             Ian J. Stratford, Manchester University,
         York, NY                                                Tony Hunter, Salk Institute for Biological                               Manchester, England
    José Baselga, Vall d’Hebron University Hospital,                  Studies, La Jolla, CA                                         Joel E. Tepper, University of North Carolina,
         Barcelona, Spain                                        Elizabeth M. Jaffee, Sidney Kimmel                                       Chapel Hill, NC
    Jean-Yves Blay, Unité INSERM , Lyon, France                       Comprehensive Cancer Center, Baltimore,                       Joseph E. Tomaszewski, National Cancer
    Gideon Bollag, Plexxikon, Inc., Berkeley, CA                      MD                                                                  Institute, Rockville, MD
    Nils Brünner, Royal Veterinary and Agriculture               Patricia LoRusso, Wayne State University,                          Takashi Tsuruo, University of Tokyo, Tokyo,
         University, Frederiksberg, Denmark                           Detroit, MI                                                         Japan
    Angelika M. Burger, Sunnybrook & Women’s                     Scott W. Lowe, Cold Spring Harbor Laboratory,                      Christopher J. Twelves, Beatson Oncology
         College Health Science Centre, Toronto,                      Cold Spring Harbor, NY                                              Center, Glasgow, Scotland
         Canada                                                  Lawrence J. Marnett, Vanderbilt University                         Paul Workman, Cancer Research UK, Sutton,
    Michaele C. Christian, National Cancer                            Medical Center, Nashville, TN                                       England
         Institute, Bethesda, MD                                 Frank McCormick, UCSF Cancer Center and                            James A. Zwiebel, National Cancer Institute,
    Robert L. Cohen, Genentech, Inc., South San                       Cancer Research Institute, San Francisco, CA                        Rockville, MD
         Francisco, CA                                           Anthony J. Murgo, National Cancer Institute,
                                                                      Rockville, MD


                                 About the Conference Convenors: AACR-NCI-EORTC
      The American Association for Cancer Research                The National Cancer Institute (NCI), founded                      The European Organization for Research and
      (AACR), founded in 1907, is a nonprofit                     in 1971, is the principal government agency in                    Treatment of Cancer (EORTC), founded in
      scientific society of more than 20,000                      the United States charged with coordinating                       1962, was organized to conduct, develop,
      laboratory, translational, and clinical cancer              the National Cancer Program. It facilitates                       coordinate, and stimulate laboratory and
      researchers. Its mission is to prevent and cure             international cooperation in clinical trials                      clinical research in Europe and to improve the
      cancer through research, education, and                     involving U.S. and foreign collaborating                          management of cancer and related problems
      communication. This work is carried out                     institutions.                                                     by increasing survival and quality of life
      through high-quality scientific programs in all                                                                               for patients.
      disciplines in the cancer field.



2              Abstract Deadline: August 4, 2003                                                                                                     November 17-21, 2003